Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead
{{output}}
The emergence of anti-vascular endothelial growth factor (anti-VEGF) therapy has marked a paradigm shift in the treatment of retinal and choroidal vascular diseases. Following the identification of VEGF as a central mediator of pathological angiogenesis and va... ...